NEW ORAL HEALTH STUDY SEEKING ADULTS AGES 18-59
D
Domenick Zero, DDS, MS
Primary Investigator
Administratively Closed
18 years - 59 years
All
Phase
N/A
1 Location
Brief description of study
Researchers at the Indiana University School of Dentistry are looking for adults (ages 18-59) to take part in a study on TMD (Temporomandibular Disorder).
Detailed description of study
Who is eligible
- Adults ages 18 -59
- Must be in good general health
- Must have had head, face, neck and/or shoulder pain for longer than 3 months and are not currently being treated for TMD
- Must have had no surgery or been recommended surgical treatment for TMD
- Must not currently wear dentures
- Must not have started orthodontic treatment during the past 3 months
What is involved
- You will attend 8 visits over 6 months at the Oral Health Research Institute on the IUPUI campus
- You will receive the study drug or placebo by injection
- You will answer questionnaires and receive dental exams
Compensation
- You will get paid to attend a screening visit ($25) whether you qualify or not
- You will receive $50 cash for completing each of the seven remaining visits for a total study payment of $375 if you complete the entire study.
How To Participate
If you would like to participate in this study, please submit your information using the provided form below.
You may also reach out to the Study Coordinator, Lorena Galvez, directly at (317) 274-8838 or email logalvez@iu.edu
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: TMD,Temporomandibular Disorder
-
Age: 18 years - 59 years
-
Gender: All
Eligibility Criteria
- Adults ages 18 -59
- Must be in good general health
- Must have had head, face, neck and/or shoulder pain for longer than 3 months and are not currently being treated for TMD
- Must have had no surgery or been recommended surgical treatment for TMD
- Must not currently wear dentures
- Must not have started orthodontic treatment during the past 3 months
Study Title: A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients with Temporomandibular Disorder (CAMG334AUS01T/20-D-242)
Updated on
12 Sep 2024.
Study ID: OHRI-NOVARTIS-TMD, 10005, TX11376
